Abstract:Treatment of approximately 50% of human cancers includes the use of chemotherapy. The major problem associated with chemotherapy is the inability to deliver pharmaceuticals to specific site of the body without inducing normal tissue toxicity. Latterly, magnetic targeted drug delivery (MTD) has been used to improve the therapeutic performance of the chemotherapeutic agents and reduce the severe side effects associated with the conventional chemotherapy for malignant tumors. In this study, we were focused on designing biocompatible magnetic nanoparticles that can be used as a nanocarrier's candidate for MTD regimen. Magnetic gold nanoparticles (MGNPs) were prepared and functionalized with thiol-terminated polyethylene glycol (PEG), then loaded with anti-cancer drug doxorubicin (DOX). The physical properties of the prepared NPs were characterized using different techniques. Transmission electron microscopy (TEM) revealed the spherical mono-dispersed nature of the prepared MGNPs with size about 22 nm. Energy dispersive X-ray spectroscopy (EDX) assured the existence of both iron and gold elements in the prepared nanoparticles. Fourier transform infrared (FTIR) spectroscopy assessment revealed that PEG and DOX molecules were successfully loaded on the MGNPs surfaces, and the amine group of DOX is the active attachment site to MGNPs. In vivo studies proved that magnetic targeted drug delivery can provide a higher accumulation of drug throughout tumor compared with that delivered by passive targeting. This clearly appeared in tumor growth inhibition assessment, biodistribution of DOX in different body organs in addition to the histopathological examinations of treated and untreated Ehrlich carcinoma. To assess the in vivo toxic effect of the prepared formulations, several biochemical parameters such as aspartate aminotransferase (AST), alanine transaminase (ALT), lactate dehydrogenase (LDH), creatine kinase MB (CK-MB), urea, uric acid and creatinine were measured. MTD technology not only minimizes the random distribution of the chemotherapeutic agents, but also reduces their side effects to healthy tissues, which are the two primary concerns in conventional cancer therapies.

Bacterial magnetic nanoparticles as drug carriers

Bifunctional Bacterial Magnetic Nanoparticles for Tumor Targeting

Efficient Conjugation Doxorubicin to Bacterial Magnetic Nanoparticles Via a Triplex Hands Coupling Reagent

Preparation and Anti‐tumor Efficiency Evaluation of Doxorubicin‐loaded Bacterial Magnetosomes: Magnetic Nanoparticles As Drug Carriers Isolated from Magnetospirillum Gryphiswaldense

Control Generating of Bacterial Magnetic Nanoparticle-Doxorubicin Conjugates by Poly-L-Glutamic Acid Surface Modification

Preparation and Biological Characterization of Hollow Magnetic Fe3O4@C Nanoparticles As Drug Carriers with High Drug Loading Capability, Ph-Control Drug Release and MRI Properties

A novel magnetic nanoparticle drug carrier for enhanced cancer chemotherapy.

Dextran-coated Superparamagnetic Nanoparticles As Potential Cancer Drug Carriers in Vivo.

In Vitro and in Vivo Antitumor Effects of Doxorubicin Loaded with Bacterial Magnetosomes (dbms) on H22 Cells: the Magnetic Bio-Nanoparticles As Drug Carriers.

Magnetically Controllable Polymer Nanotubes from a Cyclized Crosslinker for Site-Specific Delivery of Doxorubicin

Magnetically triggered drug release from nanoparticles and its applications in anti-tumor treatment

Synergistic enhancement effect of magnetic nanoparticles on anticancer drug accumulation in cancer cells.

Doxorubicin-conjugated Mesoporous Magnetic Colloidal Nanocrystal Clusters Stabilized by Polysaccharide As a Smart Anticancer Drug Vehicle.

Doxorubicin Loaded Magnetic Polymersomes: Theranostic Nanocarriers for MR Imaging and Magneto-Chemotherapy

Magnetic Field Activated Drug Release System Based on Magnetic PLGA Microspheres for Chemo-Thermal Therapy.

The C(RgdyK)-conjugated Fe3O4 Nanoparticles with High Drug Load for Dual-Targeting Integrin Alpha(v)beta3-Expressing Cancer Cells.

Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery

Phenylboronic acid-modified magnetic nanoparticles as a platform for carbon dot conjugation and doxorubicin delivery

Preparation and characterization of β-CD modified magnetic ferrite: the case of doxorubicin

Mn-dox metal-organic nanoparticles for cancer therapy and magnetic resonance imaging

POLY(L-GLUTAMIC ACID)DENDRON BASED Ph SENSITIVE DRUG CARRIER WITH MAGNETIC NANOPARTICLE CORE